No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement

Harvard | Vancouver

Pakpoor, J, Disanto, G, Altmann, D, Pavitt, S, Turner, BP, Marta, M, Juliusson, G, Baker, D, Chataway, J and Schmierer, K. 2015. No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement. [Online]. Neurology: Neuroimmunology & Neuroinflammation. Available from: http://datacompass.lshtm.ac.uk/88/ http://dx.doi.org/10.1212/NXI.0000000000000158

Export Citation

Sharing

Description

Supplementary data published as part of a comparison of the cancer risk of cladribine and other disease-modifying drugs (DMDs) in trials containing people with relapsing multiple sclerosis (pwRMS).

Published in a 3rd party system Date: 1 October 2015
Data capture method:
Mode of data capture
Experiment
Data Creators(s): Pakpoor, J, Disanto, G, Altmann, D, Pavitt, S, Turner, BP, Marta, M, Juliusson, G, Baker, D, Chataway, J and Schmierer, K
LSHTM Faculty/Department: Faculty of Epidemiology and Population Health > Dept of Medical Statistics
Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology
Participating Institutions: London School of Hygiene & Tropical Medicine

Files

Data not available from this repository.

Dataset may be available externally from:

Related resources

LSHTM Open Access publications:

Resources

Actions

Edit Item Edit Item (admin only)